LyondellBasell (LYB) stock has had a decent performance so far in 2017. It has risen 4.3% but has underperformed the broad-based SPDR S&P 500 ETF (SPY), which rose 6.0% in the same period. LYB also underperformed its peers Dow Chemical (DOW) and DuPont (DD), which rose 11.1% and 9.7%, respectively. But it did manage to outperform Eastman Chemical (EMN), which has risen 3.1%.
Receive e-mail alerts for new research on DD:
Interested in DD?
Don’t miss the next report.
The performance of LYB stock was driven primarily by better-than-expected 4Q16 earnings. Be sure to read Market Realist’s series Did LyondellBasell’s 4Q16 Results Please Investors? The company expects minimum planned maintenance in 2017, and with the Corpus Christi expansion completed, its performance is expected to be positive.
LyondellBasell’s gains in 2017 have pushed its 100-day moving average to $87.80 as of March 9, 2017, compared to $81.80 at the beginning of 2017. As of March 9, 2017, LYB was trading 1.9% above its 100-day moving average, indicating an upward trend in the stock. LYB’s 52-week low is $69.82, and its 52-week high is $97.64.
LYB’s 14-day RSI (relative strength index) of 40 indicates that the stock is neither overbought nor oversold. An RSI level of 70 means that a stock has moved temporarily into an overbought situation, and an RSI below 30 indicates that a stock has moved temporarily into an oversold position.
In this series, we’ll take a close look at LyondellBasell’s 1Q17 dividend, analysts’ latest recommendations, and the most recent valuations.